Clinical Trial Update: Study of Anti-telomerase T CD4 Immunity in Melanoma [NA]

View source ↗

Summary

A clinical trial update about a study examining anti-telomerase T CD4 immunity in melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Melanoma | NA | Status: UNKNOWN